G&E Healthcare지앤이헬스케어

G&E Healthcare, a small KONEX-listed company, has seen its shares fall sharply over the past year, with no financial statements or news in the data to explain the business today.

G&E Healthcare (지앤이헬스케어) is a KONEX-listed company with a market value of about ₩6.7B and a share price of ₩600 as of 26 October 2026, down 38.1% over one year. The data does not include a company profile, annual financials, trailing earnings or a valuation model, so the current state of the business cannot be assessed from this pack.

What stands out

• The share price is ₩600, well below its 52-week high of ₩1,000 but above its 52-week low of ₩178, after returns of -7.3% over one month, -13.9% over three months and -38.1% over one year.
• The company has no trailing financials, annual figures, P/E, P/B or EV/EBITDA in the data, so profitability and valuation cannot be judged.
• The company paid no dividend (0% yield) according to the data.
• Foreign ownership is 0% now and was 0% sixty days ago, and 20-day net flows show retail selling of about ₩5.4M with no foreign or institutional flows recorded.
• Filings in 2026 include a share buyback decision in July and a report on the treasury stock acquisition results in October, while the earlier filings were mainly annual report amendments and an AGM result; no news headlines were found.

What to watch

• Results of the treasury stock buyback and any further buyback or share-related filings.
• Any amended or new annual report and audit filings, given several amendments to the December 2025 report in April 2026.
• Whether the company publishes a business profile, financial statements or news, since none are currently in the data.